[Home](https://github.com/mm80843/T3.5/blob/pages/index.md) >> Class: [Stakeholder](https://github.com/mm80843/T3.5/tree/main/docs/Stakeholder/index.md) >> Individual ID:PBN__Stakeholder_34 

# __Manufacturers__

## Category to which it belongs

* [The industry of creating and supplying various devices, equipment, and platforms for different sectors and users.](https://github.com/mm80843/T3.5/blob/pages/PBNCategory/PBN__PBNCategory_264.md)

## Closest similar item

* [Device manufacturer](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_1953.md)
* [Device manufacturers](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_1431.md)
* [Manufacturer](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_1882.md)
* [Manufacturing companies](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_735.md)
* [Manufacturing company](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_773.md)
* [Material manufacturers](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_1879.md)
* [Medical equipment manufacturers](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_1148.md)
* [Product owners](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_2005.md)
* [Vehicle manufacturer](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_1974.md)
* [Vehicle manufacturers](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_546.md)

## Risk affecting this stakeholder

* [Disruption of supply chains](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_10.md)
* [Lack of standardized tests and protocols for uvgi efficacy and testing](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_1392.md)
* [Poor solubility and processing of graphene materials](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_1123.md)
* [Risk of ineffective anti-sars-cov-2 coatings](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_1172.md)
* [Scalability and cost of graphene-based coatings](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_1742.md)
* [Supply chain disruption](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_1126.md)
* [Supply chain disruptions](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_1128.md)

## Risks that can be mitigated by this stakeholder

* [Challenges in ventilator production](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_10.md)
* [Disruption of supply chains](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_1392.md)
* [Inadequate mixing of room air](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_1123.md)
* [Inconvenience and cost of mask filters in smart face masks](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_901.md)
* [Inefficient negative air ionization](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_1172.md)
* [Lack of airtightness and safety concerns with reusable face shields](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_1174.md)
* [Lack of effective disinfectants](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_1173.md)
* [Lack of interoperability](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_1957.md)
* [Lack of personal protective equipment](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_2054.md)
* [Lack of protective equipment](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_1356.md)
* [Lack of standardized tests and protocols for uvgi efficacy and testing](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_1357.md)
* [Limited access to personal protective equipment ppe](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_2371.md)
* [Noise and inconvenience of personal air-purifying shields](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_2373.md)
* [Risk of adverse effects from anti-sars-cov-2 coatings](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_1125.md)
* [Risk of ineffective anti-sars-cov-2 coatings](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_1742.md)
* [Risk of low viability period of sars-cov-2 on solids](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_2368.md)
* [Risk of resistance development to anti-sars-cov-2 coatings](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_1485.md)
* [Safety concerns with 3d-printed ppe](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_2100.md)
* [Safety concerns with alternative ventilator designs](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_2376.md)
* [Scalability and cost of graphene-based coatings](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_2377.md)
* [Shortage of personal protective equipment ppe](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_1171.md)
* [Shortages of personal protective equipment ppe](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_2369.md)
* [Supply chain disruption](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_1128.md)
* [Supply chain disruptions](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_1127.md)
* [Toxicity of nanomaterials](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_2372.md)

## These stakeholders can be supported by the following general blueprint(s)

* [Implementing Disease Containment Scenarios and Supply Chain Adaptations](https://github.com/mm80843/T3.5/blob/pages/aBlueprint/PBN__aBlueprint_17.md)

## This Stakeholder belongs to this StakeholderGroup

* [Private sector](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_57.md)

## This Stakeholder belongs to this StakeholderSubgroup

* [Manufacturing and industry](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_1875.md)

## This Stakeholder can get these Benefits from mitigation measures

* [Improved supply chain efficiency](https://github.com/mm80843/T3.5/blob/pages/Benef/PBN__Benef_37.md)

## This stakeholders can act on the following general blueprint(s)

* [Implementing Biosecurity Measures and Technological Solutions to Counter Infectious Diseases](https://github.com/mm80843/T3.5/blob/pages/aBlueprint/PBN__aBlueprint_17.md)
* [Implementing Contagious Disease Containment Strategies](https://github.com/mm80843/T3.5/blob/pages/aBlueprint/PBN__aBlueprint_25.md)
* [Implementing Disease Containment Scenarios and Supply Chain Adaptations](https://github.com/mm80843/T3.5/blob/pages/aBlueprint/PBN__aBlueprint_42.md)

## Type of the stakeholder

* [At risk](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_Type_0.md)
* [Beneficiary](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_Type_2.md)
* [Risk owner](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_Type_1.md)

